Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Predictive Oncology fourth quarter 2023 earnings call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Glenn Garmont, Lifestyle Advisor. Thank you, Glenn. You may begin. welcome and thank you everyone for dialing into the predictive oncology full year 2023 financial results call first you'll hear from our chief executive officer and chairman of the board raymond venary then our chief financial officer josh blatcher will review our financials certain matters discussed on this call contain forward-looking statements these forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks uncertainties, and assumptions about our operations and the investments we make. All statements other than statements of historical fact included in the call regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans, and objectives of management are forward-looking statements. The words anticipate, believe, estimate, expect, intend, may, plan, would, target, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors, including, among other things, factors discussed under the headi...